Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Stratton, I, Kohner, E, Matthews, DR, Holman, R, Aldington, S, Turner, R
Μορφή:	Journal article
Έκδοση:	1996

Παρόμοια τεκμήρια

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Aldington, S, κ.ά.
Έκδοση: (1994)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
ανά: Stratton, I, κ.ά.
Έκδοση: (2001)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
ανά: Aldington, S, κ.ά.
Έκδοση: (1996)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Stratton, I, κ.ά.
Έκδοση: (1993)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
ανά: Kohner, E, κ.ά.
Έκδοση: (2001)

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS
ανά: Matthews, D, κ.ά.
Έκδοση: (1995)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
ανά: Matthews, DR, κ.ά.
Έκδοση: (2004)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
ανά: Kohner, E, κ.ά.
Έκδοση: (1999)

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
ανά: Kohner, E, κ.ά.
Έκδοση: (1998)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Kohner, E, κ.ά.
Έκδοση: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY
ανά: Kohner, E, κ.ά.
Έκδοση: (1993)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
ανά: Stratton, I, κ.ά.
Έκδοση: (1995)

Effects of ethnicity on metabolic control during the first six years of NIDDM
ανά: Davis, T, κ.ά.
Έκδοση: (1997)

Evaluating risk of progression to photocoagulation by retinal photography or direct ophthalmoscopy.
ανά: Stratton, I, κ.ά.
Έκδοση: (1997)

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
ανά: Davis, T, κ.ά.
Έκδοση: (1997)

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
ανά: Cull, C, κ.ά.
Έκδοση: (1997)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
ανά: Matthews, DR, κ.ά.
Έκδοση: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
ανά: Matthews, DR, κ.ά.
Έκδοση: (1998)

Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
ανά: Holman, R, κ.ά.
Έκδοση: (1996)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
ανά: Keavney, B, κ.ά.
Έκδοση: (1995)

Risk factors for presence of hard exudates at diagnosis of Type 2 diabetes and after 6 years.
ανά: Stratton, J, κ.ά.
Έκδοση: (2003)

Insulin use in NIDDM. Rationale based on pathophysiology of disease.
ανά: Turner, R, κ.ά.
Έκδοση: (1990)

No glycemic benefit from guar administration in NIDDM.
ανά: Holman, R, κ.ά.
Έκδοση: (1987)

CIGMA as a tool in the study of NIDDM.
ανά: Turner, R, κ.ά.
Έκδοση: (1988)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
ανά: Turner, R, κ.ά.
Έκδοση: (1995)

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
ανά: Scanlon, P, κ.ά.
Έκδοση: (2013)

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
ανά: Scanlon, P, κ.ά.
Έκδοση: (2014)

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
ανά: Turner, R, κ.ά.
Έκδοση: (1997)

Epidemiological issues in diabetic retinopathy.
ανά: Scanlon, P, κ.ά.
Έκδοση: (2013)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
ανά: Turner, R, κ.ά.
Έκδοση: (1988)

Sulphonylurea therapy over six years does not delay progression to diabetes
ανά: Herlihy, O, κ.ά.
Έκδοση: (2000)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
ανά: Dudley, C, κ.ά.
Έκδοση: (1995)

A Practical Manual of Diabetic Retinopathy Management
ανά: Scanlon, P, κ.ά.
Έκδοση: (2009)

Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?
ανά: Stratton, I, κ.ά.
Έκδοση: (2014)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
ανά: Rachman, J, κ.ά.
Έκδοση: (1996)

Segregation analysis of NIDDM in Caucasian families.
ανά: Cook, J, κ.ά.
Έκδοση: (1994)

STUDY DESIGN OF THE UK PROSPECTIVE DIABETES STUDY AND PROGRESS OF EYE DATA
ανά: Stratton, I, κ.ά.
Έκδοση: (1993)

Reinforced healthy living advice over six years does not delay progression to diabetes
ανά: Dyson, P, κ.ά.
Έκδοση: (2000)

Thyroid dysfunction and its relation with diabetes mellitus (NIDDM)
ανά: H.R.Bazrafshan (M.D), κ.ά.
Έκδοση: (2000-03-01)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
ανά: Rachman, J, κ.ά.
Έκδοση: (1998)